{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:53:22Z","timestamp":1781481202435,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cincinnati Children's Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04908-3","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:36:43Z","timestamp":1776915403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotypic and phenotypic spectrum of hereditary spastic paraplegia 56: insights from novel CYP2U1 variants and a literature review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2794-3642","authenticated-orcid":false,"given":"Kochakorn","family":"Buasri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7213-5449","authenticated-orcid":false,"given":"Kristin","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-4195","authenticated-orcid":false,"given":"Devesh C.","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-4556","authenticated-orcid":false,"given":"Sumit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrah","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-1093","authenticated-orcid":false,"given":"Jaime","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1717-7967","authenticated-orcid":false,"given":"Casey J.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7053-2449","authenticated-orcid":false,"given":"Anne","family":"Slavotinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"6","key":"4908_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","volume":"91","author":"C Tesson","year":"2012","unstructured":"Tesson C, et al. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet. 2012;91(6):1051\u201364.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"4908_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00415-013-7206-6","volume":"261","author":"A Citterio","year":"2014","unstructured":"Citterio A, et al. Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol. 2014;261(2):373\u201381.","journal-title":"J Neurol"},{"issue":"6\u20137","key":"4908_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neurol.2015.02.017","volume":"171","author":"S Klebe","year":"2015","unstructured":"Klebe S, Stevanin G, Depienne C. Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting. Rev Neurol (Paris). 2015;171(6\u20137):505\u201330.","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"4908_CR4","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.ejpn.2016.05.013","volume":"20","author":"A Kariminejad","year":"2016","unstructured":"Kariminejad A, et al. CYP2U1 mutations in two Iranian patients with activity induced dystonia, motor regression and spastic paraplegia. Eur J Paediatr Neurol. 2016;20(5):782\u20137.","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"4908_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10048-016-0495-z","volume":"17","author":"KR Kumar","year":"2016","unstructured":"Kumar KR, et al. Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing. Neurogenetics. 2016;17(4):265\u201370.","journal-title":"Neurogenetics"},{"issue":"4","key":"4908_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00415-016-8066-7","volume":"263","author":"L Leonardi","year":"2016","unstructured":"Leonardi L, et al. Pigmentary degenerative maculopathy as prominent phenotype in an Italian SPG56\/CYP2U1 family. J Neurol. 2016;263(4):781\u20133.","journal-title":"J Neurol"},{"issue":"3","key":"4908_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejpn.2016.02.001","volume":"20","author":"M Masciullo","year":"2016","unstructured":"Masciullo M, et al. Hereditary spastic paraplegia: Novel mutations and expansion of the phenotype variability in SPG56. Eur J Paediatr Neurol. 2016;20(3):444\u20138.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"4908_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00415-017-8393-3","volume":"264","author":"A Iodice","year":"2017","unstructured":"Iodice A, et al. Long-term follow-up in spastic paraplegia due to SPG56\/CYP2U1: age-dependency rather than genetic variability? J Neurol. 2017;264(3):586\u20138.","journal-title":"J Neurol"},{"issue":"11","key":"4908_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/jhg.2017.77","volume":"62","author":"G Minase","year":"2017","unstructured":"Minase G, et al. An atypical case of SPG56\/CYP2U1-related spastic paraplegia presenting with delayed myelination. J Hum Genet. 2017;62(11):997\u20131000.","journal-title":"J Hum Genet"},{"issue":"1","key":"4908_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.23359","volume":"39","author":"CM Durand","year":"2018","unstructured":"Durand CM, et al. CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56. Hum Mutat. 2018;39(1):140\u201351.","journal-title":"Hum Mutat"},{"key":"4908_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jocn.2019.06.039","volume":"67","author":"S Zulfiqar","year":"2019","unstructured":"Zulfiqar S, et al. Whole exome sequencing identifies novel variant underlying hereditary spastic paraplegia in consanguineous Pakistani families. J Clin Neurosci. 2019;67:19\u201323.","journal-title":"J Clin Neurosci"},{"key":"4908_CR12","doi-asserted-by":"publisher","first-page":"116669","DOI":"10.1016\/j.jns.2020.116669","volume":"411","author":"F Bibi","year":"2020","unstructured":"Bibi F, et al. Rare novel CYP2U1 and ZFYVE26 variants identified in two Pakistani families with spastic paraplegia. J Neurol Sci. 2020;411:116669.","journal-title":"J Neurol Sci"},{"issue":"5","key":"4908_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/joim.13193","volume":"289","author":"A Legrand","year":"2021","unstructured":"Legrand A, et al. Pseudoxanthoma elasticum overlaps hereditary spastic paraplegia type 56. J Intern Med. 2021;289(5):709\u201325.","journal-title":"J Intern Med"},{"key":"4908_CR14","doi-asserted-by":"crossref","unstructured":"Pujol C et al. Implication of folate deficiency in CYP2U1 loss of function. J Exp Med. 2021;218(11):e20210846.","DOI":"10.1084\/jem.20210846"},{"issue":"1","key":"4908_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/jpn.JPN_86_20","volume":"16","author":"IK Sharawat","year":"2021","unstructured":"Sharawat IK, Panda PK, Dawman L. Spastic Paraplegia-56 due to a Novel CYP2U1 Truncating Mutation in an Indian Boy: A New Report and Literature Review. J Pediatr Neurosci. 2021;16(1):71\u20134.","journal-title":"J Pediatr Neurosci"},{"issue":"1","key":"4908_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10048-024-00789-1","volume":"26","author":"Z Sadr","year":"2024","unstructured":"Sadr Z, et al. Three Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69. Neurogenetics. 2024;26(1):12.","journal-title":"Neurogenetics"},{"key":"4908_CR17","first-page":"101023","volume":"38","author":"SS Wong","year":"2024","unstructured":"Wong SS, et al. CYP2U1: An emerging treatable neurometabolic disease with cerebral folate deficiency in 2 Chinese brothers. Mol Genet Metab Rep. 2024;38:101023.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"4908_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12883-025-04211-7","volume":"25","author":"HP Yu","year":"2025","unstructured":"Yu HP, et al. Diagnostic journey and genetic analysis of a novel homozygous CYP2U1 mutation causing autosomal recessive spastic paraplegia type 56 (SPG56) in a consanguineous family. BMC Neurol. 2025;25(1):207.","journal-title":"BMC Neurol"},{"key":"4908_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pediatrneurol.2022.02.007","volume":"130","author":"TF Panwala","year":"2022","unstructured":"Panwala TF, et al. Childhood-Onset Hereditary Spastic Paraplegia (HSP): A Case Series and Review of Literature. Pediatr Neurol. 2022;130:7\u201313.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"4908_CR20","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10072-022-06516-8","volume":"44","author":"SM Fereshtehnejad","year":"2023","unstructured":"Fereshtehnejad SM, et al. Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis. Neurol Sci. 2023;44(3):947\u201359.","journal-title":"Neurol Sci"},{"key":"4908_CR21","doi-asserted-by":"publisher","first-page":"690899","DOI":"10.3389\/fmolb.2021.690899","volume":"8","author":"LEO Elsayed","year":"2021","unstructured":"Elsayed LEO, et al. Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview. Front Mol Biosci. 2021;8:690899.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4908_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gim.2022.09.013","volume":"25","author":"H Morsy","year":"2023","unstructured":"Morsy H, et al. Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia. Genet Med. 2023;25(1):76\u201389.","journal-title":"Genet Med"},{"issue":"2","key":"4908_CR23","doi-asserted-by":"publisher","first-page":"e200250","DOI":"10.1212\/NXG.0000000000200250","volume":"11","author":"M Salari","year":"2025","unstructured":"Salari M, et al. Review of the Genetic Spectrum of Hereditary Spastic Paraplegias in the Middle East and North Africa Regions. Neurol Genet. 2025;11(2):e200250.","journal-title":"Neurol Genet"},{"issue":"1","key":"4908_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cge.70009","volume":"109","author":"T Duzenli","year":"2026","unstructured":"Duzenli T, et al. Identifying the Fourth Patient With Spastic Paraplegia 90, Extending the Phenotype Spectrum. Clin Genet. 2026;109(1):155\u201360.","journal-title":"Clin Genet"},{"key":"4908_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.12703\/r\/10-27","volume":"10","author":"P Lallemant-Dudek","year":"2021","unstructured":"Lallemant-Dudek P, Darios F, Durr A. Recent advances in understanding hereditary spastic paraplegias and emerging therapies. Fac Rev. 2021;10:27.","journal-title":"Fac Rev"},{"issue":"3","key":"4908_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2004.01.110","volume":"315","author":"M Karlgren","year":"2004","unstructured":"Karlgren M, et al. Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun. 2004;315(3):679\u201385.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4908_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.plefa.2010.06.005","volume":"83","author":"A Devos","year":"2010","unstructured":"Devos A, et al. Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation. Prostaglandins Leukot Essent Fat Acids. 2010;83(2):105\u201310.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"4908_CR28","doi-asserted-by":"crossref","unstructured":"El Matri K et al. Macular Dystrophy with Bilateral Macular Telangiectasia Related to the CYP2U1 Pathogenic Variant Assessed with Multimodal Imaging Including OCT-Angiography. Genes (Basel), 2021. 12(11).","DOI":"10.3390\/genes12111795"},{"issue":"1","key":"4908_CR29","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.xops.2024.100618","volume":"5","author":"FB Sallo","year":"2025","unstructured":"Sallo FB, et al. Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1. Ophthalmol Sci. 2025;5(1):100618.","journal-title":"Ophthalmol Sci"},{"key":"4908_CR30","doi-asserted-by":"crossref","unstructured":"Theobald K, et al. Expanding Access to Genome Sequencing: Higher Diagnostic Yield in Self-Referred Participants From the CincyKidsSeq Study and Implications for Hybrid Models of Genetic Service Delivery. Clin Genet; 2025.","DOI":"10.1111\/cge.70105"},{"issue":"5","key":"4908_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"4908_CR32","unstructured":"Medicine. NL, editor. o., PubMed. 2025."},{"issue":"8","key":"4908_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1101\/gr.3715005","volume":"15","author":"A Siepel","year":"2005","unstructured":"Siepel A, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034\u201350.","journal-title":"Genome Res"},{"key":"4908_CR34","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013 Chapter 7: p. Unit7 20.","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"4908_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-neuro-062111-150400","volume":"35","author":"C Blackstone","year":"2012","unstructured":"Blackstone C. Cellular pathways of hereditary spastic paraplegia. Annu Rev Neurosci. 2012;35:25\u201347.","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"4908_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1373\/49.2.295","volume":"49","author":"SJ Moat","year":"2003","unstructured":"Moat SJ, et al. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem. 2003;49(2):295\u2013302.","journal-title":"Clin Chem"},{"key":"4908_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.2011.06311.x","volume":"1245","author":"KC Lloyd","year":"2011","unstructured":"Lloyd KC. A knockout mouse resource for the biomedical research community. Ann N Y Acad Sci. 2011;1245:24\u20136.","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"4908_CR38","first-page":"1467","volume":"8","author":"E Tuck","year":"2015","unstructured":"Tuck E, et al. A gene expression resource generated by genome-wide lacZ profiling in the mouse. Dis Model Mech. 2015;8(11):1467\u201378.","journal-title":"Dis Model Mech"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04908-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:37:33Z","timestamp":1781480253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04908-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4908"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04908-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients 1 and 2 were enrolled through a protocol approved by the Institutional Review Board (IRB) at Cincinnati Children\u2019s Hospital Medical Center, (Cincinnati Children\u2019s Institutional Review Board (IRB), protocol number 2023\u2009\u2212\u20090480), in accordance with institutional policies. The IRB at Cincinnati Children\u2019s Hospital Medical Center meets weekly and is registered with the Office for Human Research protection (OHRP) in compliance with both Health and Human services (HHS) and Food and Drug Administration (FDA) regulations regarding registration of IRB \u2013 the registration number is IRB00000231. Patient 3 was not enrolled in an IRB-approved protocol due to the testing being undertaken as part of clinical care. The IRB from Emory University has used five case studies as a threshold, above which a case study\/series would be reviewed as \u201cresearch.\u201d In this case, only one patient is reported from that Institution. All experiments and activities were performed according to relevant guidelines and regulations, including the Declaration of Helsinki. The written informed consent to participate was obtained from the parent or legal guardian of each patient under 18 years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details and clinical images was obtained from the parent or legal guardian of each patient under 18 years of age. No identifying details have been included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}